SOPHiA GENETICS SA (SOPH) — Earnings Call Analysis & IR Page

SOPHiA GENETICS SA is a Healthcare company operating in Health Information Services with a $672.1M market cap.

Most recent earnings call: Q1 FY26 on May 5, 2026.

19 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.80

ir.sophiagenetics.com

Extracted from Unknown source, 2026-08-30.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 19 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SOPH.

$ curl https://api.spokenalpha.com/v1/companies/SOPH

Get an API key API docs

FAQ

Frequently asked about SOPH

Where can I find SOPHiA GENETICS SA's (SOPH) earnings call transcripts?

Spoken Alpha indexes SOPH's earnings call transcripts at https://spokenalpha.com/companies/SOPH. Each call links to attributed speakers and parsed analyst Q&A. SOPHiA GENETICS SA's own investor relations page is at https://ir.sophiagenetics.com/.

When was SOPHiA GENETICS SA's most recent earnings call?

SOPHiA GENETICS SA (SOPH) held its most recent earnings call on 2026-05-05, covering fiscal Q1 2026.

What sector is SOPH in?

SOPHiA GENETICS SA (SOPH) operates in the Healthcare sector (Health Information Services industry).

Overview